Literature DB >> 15203199

The MTG proteins: chromatin repression players with a passion for networking.

Stefano Rossetti1, André T Hoogeveen, Nicoletta Sacchi.   

Abstract

The human myeloid translocation genes (MTGs) encode a family of proteins with a modular structure that can be traced to the Drosophila protein nervy. The nuclear MTGs can mediate the formation of complex protein networks among nuclear corepressors (Sin3a, N-CoR, SMRT), chromatin-modifying enzymes (histone deacetylases), and DNA-binding transcription factors. Hierarchical modulation of repression at target genes by MTG protein complexes is likely required for fine spatial and temporal gene regulation during development and differentiation. Genomic changes can disrupt these sophisticated protein networks and underlie novel pathogenic causes of cancer and neurodegeneration. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15203199     DOI: 10.1016/j.ygeno.2004.02.011

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  19 in total

1.  Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits.

Authors:  Matteo Brioschi; John Fischer; Roberto Cairoli; Stefano Rossetti; Laura Pezzetti; Michele Nichelatti; Mauro Turrini; Francesca Corlazzoli; Barbara Scarpati; Enrica Morra; Nicoletta Sacchi; Alessandro Beghini
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

2.  Interaction of MTG family proteins with NEUROG2 and ASCL1 in the developing nervous system.

Authors:  Joshua D Aaker; Andrea L Patineau; Hyun-Jin Yang; David T Ewart; Yasushi Nakagawa; Steven C McLoon; Naoko Koyano-Nakagawa
Journal:  Neurosci Lett       Date:  2010-03-07       Impact factor: 3.046

3.  Transient expression of Ngn3 in Xenopus endoderm promotes early and ectopic development of pancreatic beta and delta cells.

Authors:  Daniel Oropeza; Marko Horb
Journal:  Genesis       Date:  2012-01-30       Impact factor: 2.487

4.  Human BAHD1 promotes heterochromatic gene silencing.

Authors:  Hélène Bierne; To Nam Tham; Eric Batsche; Anne Dumay; Morwenna Leguillou; Sophie Kernéis-Golsteyn; Béatrice Regnault; Jacob S Seeler; Christian Muchardt; Jean Feunteun; Pascale Cossart
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-03       Impact factor: 11.205

5.  Characterization of a t(5;8)(q31;q21) translocation in a patient with mental retardation and congenital heart disease: implications for involvement of RUNX1T1 in human brain and heart development.

Authors:  Litu Zhang; Zeynep Tümer; Kjeld Møllgård; Gotthold Barbi; Eva Rossier; Eske Bendsen; Rikke Steensbjerre Møller; Reinhard Ullmann; Jian He; Nickolas Papadopoulos; Niels Tommerup; Lars Allan Larsen
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

6.  Regional expression of MTG genes in the developing mouse central nervous system.

Authors:  Amin Alishahi; Naoko Koyano-Nakagawa; Yasushi Nakagawa
Journal:  Dev Dyn       Date:  2009-08       Impact factor: 3.780

7.  Feedback regulation of NEUROG2 activity by MTGR1 is required for progression of neurogenesis.

Authors:  Joshua D Aaker; Andrea L Patineau; Hyun-Jin Yang; David T Ewart; Wuming Gong; Tongbin Li; Yasushi Nakagawa; Steven C McLoon; Naoko Koyano-Nakagawa
Journal:  Mol Cell Neurosci       Date:  2009-07-28       Impact factor: 4.314

8.  The transcriptional co-repressor myeloid translocation gene 16 inhibits glycolysis and stimulates mitochondrial respiration.

Authors:  Parveen Kumar; Vladimir V Sharoyko; Peter Spégel; Urban Gullberg; Hindrik Mulder; Inge Olsson; Ram Ajore
Journal:  PLoS One       Date:  2013-07-01       Impact factor: 3.240

Review 9.  RUNX1: A microRNA hub in normal and malignant hematopoiesis.

Authors:  Stefano Rossetti; Nicoletta Sacchi
Journal:  Int J Mol Sci       Date:  2013-01-14       Impact factor: 5.923

10.  Novel RNA-binding properties of the MTG chromatin regulatory proteins.

Authors:  Stefano Rossetti; Leontine van Unen; Nicoletta Sacchi; Andre T Hoogeveen
Journal:  BMC Mol Biol       Date:  2008-10-24       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.